ABCB1 Modulation Does Not Circumvent Drug Extrusion From Primitive Leukemic Progenitor Cells and May Preferentially Target Residual Normal Cells in Acute Myelogenous Leukemia

Clinical Cancer Research- United States

doi 10.1158/1078-0432.ccr-05-1945

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Flavaglines Target Primitive Leukemia Cells and Enhance Anti-Leukemia Drug Activity

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Heterogeneity of Cultured Leukemic Lymphoid Progenitor Cells From B Cell Precursor Acute Lymphoblastic Leukemia (ALL) Patients.

Journal of Clinical Investigation
Medicine
1987English

Subclassification of Patients With Acute Myelogenous Leukemia Based on Chemokine Responsiveness and Constitutive Chemokine Release by Their Leukemic Cells

Haematologica
Hematology
2007English

Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID MouseIn Vivo

Journal of Oncology
Oncology
2012English

Leukemic Retinophaty, the First Manifestation in a Case of Acute Myelogenous Leukemia

Romanian journal of ophthalmology
Medicine
2018English

Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection

Folia Medica
Medicine
2016English

Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells

Science
MultidisciplinaryPhilosophy of ScienceHistory
2008English

BETP Degradation Simultaneously Targets Acute Myelogenous Leukemia Stem Cells and the Microenvironment

Journal of Clinical Investigation
Medicine
2019English

MN1–Fli1 Oncofusion Transforms Murine Hematopoietic Progenitor Cells Into Acute Megakaryoblastic Leukemia Cells

Oncogenesis
Cancer ResearchMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy